Welcome to the MacDonald Obstetric Medicine Society
Welcome to the website of the MacDonald Obstetric Medicine Society (the UK obstetric medicine society). We aim to support clinicians across all disciplines to improve pregnancy outcomes for mothers with medical problems. This website seeks to provide guidance and resources, as well as a forum for discussion to encourage the formal expansion of this exciting specialty.
Updated advice on COVID-19 vaccination in pregnancy and women who are breastfeeding
As we see another inflection point in cases of SARS-CoV2; we have good news that the Oxford University/AstraZeneca’s COVID-19 vaccination has also received MHRA approval today. This is some comfort but due to the lack of inclusion of pregnant or breastfeeding women in the vaccine trials, data is sparse as to its efficacy and safety in this vulnerable group.
As clinicians in our particular speciality we are most acutely aware that this is, again, the most exquisite of ironies – our most vulnerable women are being discouraged from being given the vaccine.
Today, however the Joint Committee on Vaccination and Immunisation (JCVI) have also published their latest advice.
In response, MOMS together with RCOG, RCM, UKTIS, UKOSS, BMFMS and NPEU have produced a joint statement in support of COVID-19 vaccination in clinically vulnerable pregnant women.
We are responsible for ensuring our women get the right advice to make the right decision about Covid-19 vaccination.
President MacDonald Obstetric Medicine Society
Updated Guidance Document on Valproate
Updated guidance on the prescription of valproate for female patients during childbearing years has been published this week.
The guidance has been produced to inform all healthcare professionals of best practice around the use and prescribing of valproate and to support them to navigate situations that could arise as a result of prescribing valproate to women during childbearing years, given the significant risk of birth defects and developmental disorders that can occur if it is taken during pregnancy.
First published last year, the updated guidance reflects minor changes made by the MHRA and changes to GMC decision-making guidelines, as well as updated input from all contributing organisations, to give healthcare professionals updated practical information and guidance on prescribing valproate to women with bipolar disorder or epilepsy, the only licensed indications for its use. It has been authored by Dr Judy Shakespeare FRCGP and Dr Sanjay M Sisodiya FRCP on behalf of the Royal College of General Practitioners, Association of British Neurologists and Royal College of Physicians, and endorsed by 19 other medical organisations.